Anti-angiogenic effects of purine inhibitors of cyclin dependent kinases.

Johanna Liebl; Vladimir Krystof; György Vereb; Lili Takács; Miroslav Strnad; Paul Pechan; Libor Havlicek; Marek Zatloukal; Robert Fürst; Angelika M Vollmar; Stefan Zahler

doi:10.1007/s10456-011-9212-6

Anti-angiogenic effects of purine inhibitors of cyclin dependent kinases.

Johanna Liebl, Vladimir Krystof, György Vereb, Lili Takács, Miroslav Strnad, Paul Pechan, Libor Havlicek, Marek Zatloukal, Robert Fürst, Angelika M Vollmar, Stefan Zahler

Research output: Contribution to journal › Original Article › peer-review

27 Citations (Web of Science)

Original language	English
Pages (from-to)	28-91
Journal	ANGIOGENESIS
Volume	14
Issue number	3
DOIs	https://doi.org/10.1007/s10456-011-9212-6
Publication status	Published - 2011

Keywords

OLOMOUCINE-II
CELL-CYCLE
ROSCOVITINE
ACTIVATION
MALIGNANCIES
ANTICANCER
INDUCTION
APOPTOSIS
ANALOGS
TARGETS

Access to Document

10.1007/s10456-011-9212-6

Cite this

@article{99cd3233de46464180f3dd45f6a0b1cf,

title = "Anti-angiogenic effects of purine inhibitors of cyclin dependent kinases.",

keywords = "OLOMOUCINE-II, CELL-CYCLE, ROSCOVITINE, ACTIVATION, MALIGNANCIES, ANTICANCER, INDUCTION, APOPTOSIS, ANALOGS, TARGETS",

author = "Johanna Liebl and Vladimir Krystof and Gy{\"o}rgy Vereb and Lili Tak{\'a}cs and Miroslav Strnad and Paul Pechan and Libor Havlicek and Marek Zatloukal and Robert F{\"u}rst and Vollmar, {Angelika M} and Stefan Zahler",

year = "2011",

doi = "10.1007/s10456-011-9212-6",

language = "English",

volume = "14",

pages = "28--91",

journal = "ANGIOGENESIS",

issn = "0969-6970",

publisher = "Kluwer Academic Publishers ",

number = "3",

}

TY - JOUR

T1 - Anti-angiogenic effects of purine inhibitors of cyclin dependent kinases.

AU - Liebl, Johanna

AU - Krystof, Vladimir

AU - Vereb, György

AU - Takács, Lili

AU - Strnad, Miroslav

AU - Pechan, Paul

AU - Havlicek, Libor

AU - Zatloukal, Marek

AU - Fürst, Robert

AU - Vollmar, Angelika M

AU - Zahler, Stefan

PY - 2011

Y1 - 2011

KW - OLOMOUCINE-II

KW - CELL-CYCLE

KW - ROSCOVITINE

KW - ACTIVATION

KW - MALIGNANCIES

KW - ANTICANCER

KW - INDUCTION

KW - APOPTOSIS

KW - ANALOGS

KW - TARGETS

U2 - 10.1007/s10456-011-9212-6

DO - 10.1007/s10456-011-9212-6

M3 - Original Article

C2 - 21487803

SN - 0969-6970

VL - 14

SP - 28

EP - 91

JO - ANGIOGENESIS

JF - ANGIOGENESIS

IS - 3

ER -